# Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.

> **NCT06971965** · NA · NOT_YET_RECRUITING · sponsor: **National Cancer Center, Korea** · enrollment: 578 (estimated)

## Conditions studied

- Thyroid Cancer
- Papillary Thyroid Carcinoma

## Interventions

- **DRUG:** Levothyroxin

## Key facts

- **NCT ID:** NCT06971965
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-02
- **Primary completion:** 2027-12-31
- **Final completion:** 2032-12-31
- **Target enrollment:** 578 (ESTIMATED)
- **Last updated:** 2025-05-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06971965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06971965, "Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06971965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*